Latest Breaking News On - Pellis negative opinion - Page 1 : comparemela.com

Apellis Pharmaceuticals, Inc. (APLS) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a negative opinion for Pegcetacoplan for geographic atrophy or GA.

Jeffrey eiseleMore such health newsApellis pharmaceuticals incApellis pharmaceuticalsEuropean medicines agencyMedicinal productsHuman useNegative opinionGeographic atrophyPellis negative opinion